Medivir subsidiary BioPhausia AB sells generics business
Huddinge, Sweden - Medivir AB (OMX: MVIR), is an expanding, research-based specialty pharmaceutical company focusing on infectious diseases. Medivir reports that on 25 August, BioPhausia AB reached an agreement to sell its generics business in the form of subsidiary BMM Pharma AB to Bluefish Pharmaceuticals AB for SEK 26 m plus the value of inventories, some SEK 12 m. The staff of BMM Pharma will not transfer in the acquisition. “This deal is a natural last step in the concentration and focus of BioPhausia’s business, which began about a year ago. We